Enzymatica AB (publ) (STO:ENZY)
2.460
-0.120 (-4.65%)
Sep 10, 2025, 2:23 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 626.26 million as of September 10, 2025. Its market cap has increased by 40.00% in one year.
Market Cap
626.26M
Enterprise Value
582.56M
Revenue
50.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.46
Market Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 626.26M, an increase of 474.93%. That is a compound annual growth rate of 13.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 9, 2025 | 626.26M | 83.70% |
Dec 30, 2024 | 340.92M | -47.39% |
Dec 29, 2023 | 647.99M | -12.33% |
Dec 30, 2022 | 739.16M | -43.36% |
Dec 30, 2021 | 1.31B | -51.13% |
Dec 30, 2020 | 2.67B | 371.03% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 95.90B |
Sectra AB | 62.81B |
Getinge AB | 57.14B |
Camurus AB | 43.26B |
Medicover AB | 40.46B |
Asker Healthcare Group AB | 35.67B |
BioArctic AB | 25.10B |
AddLife AB | 22.03B |